Non-GMO | Gluten Free | 120 Vegetarian Capsules | NPN 80115574
Stops UTI infections before they start
- Helps prevent recurrent urinary tract infections (UTIs)
- Targets and naturally flushes E. coli from the bladder
- Prevents bacteria from sticking to the urinary tract wall
- Eliminates urinary pathogens without affecting gut microflora
- Supports a healthy urinary tract
WomenSense D-Mannose uses a formula made with the naturally occurring simple-sugar D-mannose to stop UTI infections before they start. When taken daily, D-mannose helps reduce the risk of recurrent urinary tract infections (UTIs) in women. Each daily dose provides 2000 mg of D-mannose to help flush E. coli from the urinary tract without interfering with healthy blood sugar regulation.
Recommended adult dose: 2 capsules 2 times daily or as directed by a health care practitioner.
This product does not contain artificial preservatives, colours, or sweeteners; no dairy, starch, wheat, gluten, yeast, soy, corn, egg, fish, shellfish, animal products, salt, tree nuts, or GMOs. Suitable for vegetarians/vegans.
Each Vegetarian Capsule Contains
Dibasic calcium phosphate dihydrate, vegetarian capsule (carbohydrate gum [cellulose], purified water), microcrystalline cellulose, vegetable grade magnesium stearate (lubricant), stearic acid, silica.
Do you have a question? Don’t hesitate to ask.
1. Ala-Jaakkola, R., Laitila, A., Ouwehand, A.C. et al. (2022). Role of D-mannose in urinary tract infections – a narrative review. Nutr J, 21(18).
2. Kranjčec, B., Papeš, D., Altarac, S. (2014). D-mannose powder for prophylaxis of recurrent urinary tract infections in women: A randomized clinical trial. World J Urol, 32(1), 79-84.
3. Lenger, S.M., Bradley, M.S., Thomas, D.A., et al. (2020). D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: A systematic review and meta-analysis. AJOG, 223(2), 265.e1-13.
4. Marchiori, D., & Zanello, P.P. (2017). Efficacy of N-acetylcysteine, D-mannose and Morinda citrifolia to treat recurrent cystitis in breast cancer survivals. In Vivo, 31(5), 931-6.
5. Rodriguez-Mañas, L. (2020). Urinary tract infections in the elderly: A review of disease characteristics and current treatment options. Drugs Context, 9, 1-8.
6. Scaglione, F., Musazzi, U.M., & Minghetti, P. (2021). Considerations on D-mannose mechanism of action and consequent classification of marketed healthcare products. Front Pharmacol, 12, 636377.